Effect of Lysine at C-terminus of the Dmt-Tic Opioid Pharmacophore
Overview
Authors
Affiliations
Substitution of Gly with side-chain-protected or unprotected Lys in lead compounds containing the opioid pharmacophore Dmt-Tic [H-Dmt-Tic-Gly-NH-CH(2)-Ph, mu agonist/delta antagonist; H-Dmt-Tic-Gly-NH-Ph, mu agonist/delta agonist; and H-Dmt-Tic-NH-CH(2)-Bid, delta agonist (Bid = 1H-benzimidazole-2-yl)] yielded a new series of compounds endowed with distinct pharmacological activities. Compounds (1-10) included high delta- (Ki(delta) = 0.068-0.64 nM) and mu-opioid affinities (Ki(mu) = 0.13-5.50 nM), with a bioactivity that ranged from mu-opioid agonism {10, H-Dmt-Tic-NH-CH[(CH2)4-NH2]-Bid (IC50 GPI = 39.7 nM)} to a selective mu-opioid antagonist [3, H-Dmt-Tic-Lys-NH-CH2-Ph (pA2(mu) = 7.96)] and a selective delta-opioid antagonist [5, H-Dmt-Tic-Lys(Ac)-NH-Ph (pA2(delta) = 12.0)]. The presence of a Lys linker provides new lead compounds in the formation of opioid peptidomimetics containing the Dmt-Tic pharmacophore with distinct agonist and/or antagonist properties.
Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells.
Cai B, El Daibani A, Bai Y, Che T, Krusemark C JACS Au. 2023; 3(4):1076-1088.
PMID: 37124302 PMC: 10131204. DOI: 10.1021/jacsau.2c00674.
Selection of DNA-Encoded Libraries to Protein Targets within and on Living Cells.
Cai B, Kim D, Akhand S, Sun Y, Cassell R, Alpsoy A J Am Chem Soc. 2019; 141(43):17057-17061.
PMID: 31613623 PMC: 7057806. DOI: 10.1021/jacs.9b08085.
Bruna-Larenas T, Gomez-Jeria J Int J Med Chem. 2014; 2012:682495.
PMID: 25379287 PMC: 4207423. DOI: 10.1155/2012/682495.
Engineering endomorphin drugs: state of the art.
Lazarus L, Okada Y Expert Opin Ther Pat. 2012; 22(1):1-14.
PMID: 22214283 PMC: 3253703. DOI: 10.1517/13543776.2012.646261.
Current research on opioid receptor function.
Feng Y, He X, Yang Y, Chao D, Lazarus L, Xia Y Curr Drug Targets. 2011; 13(2):230-46.
PMID: 22204322 PMC: 3371376. DOI: 10.2174/138945012799201612.